POET Technologies heads into its September-quarter report with a striking mismatch between what the Street is modeling and how the stock has traded. Analysts expect revenue to jump to roughly $1.6 million, more than double the $0.6 million booked last quarter and over five times the $0.3 million from a year ago. Yet the shares have lost about 42% since the last report, and bullish sentiment has all but evaporated. Either the market doubts the ramp, or it is no longer willing to pay in advance for one. This report should show which view is closer to the truth.

The numbers themselves are small, and that is the point. Consensus calls for a loss of $0.07 per share, unchanged from last quarter and a 36% improvement from the $0.11 loss a year earlier. The projected revenue growth of nearly 437% looks spectacular on paper, but it comes off a base of a few hundred thousand dollars. For a pre-scale photonics developer, the headline percentage matters less than whether the sequential step-up is real, repeatable and tied to products that customers are actually buying in volume rather than sampling. A figure near $1.6 million would mark the company's most meaningful quarterly sales so far. A figure that stalls near last quarter's level would suggest the expected ramp is slipping to the right.

With no formal guidance in hand, the burden of proof falls on the release and the commentary around it. The core question is whether revenue from POET's optical light source and photonic sensing products is beginning to convert from engineering and qualification work into recurring production orders. Evidence that would strengthen the story includes clearer disclosure about which customers or product lines are driving sales, signs that orders extend beyond a single quarter, and any discussion of manufacturing readiness in its Singapore and North American operations. Evidence that would weaken it includes lumpy revenue that depends on one-time shipments, further delays in customer qualifications, or vague language about timing. Flat losses per share despite higher revenue would also be worth scrutinizing, since it would show how much spending is still running ahead of sales.

Sentiment has swung sharply. Going into the prior report, readings were roughly 78% bullish. Today they sit barely above neutral at 2%. That collapse mirrors the stock's slide, which far outpaced the S&P 500's 5% decline over the same stretch and leaves POET about 37 percentage points behind the broader market. Expectations around the stock, if not around the revenue line, have reset dramatically lower. That can cut both ways. A clean delivery on the ramp could land on a skeptical audience primed to be surprised, while another quarter of promise without proof could reinforce the market's growing impatience.

The chart reflects that loss of faith. At $5.07, the shares trade well below their 200-day moving average of $8.18 and sit in the lower part of the $4 to $10 range established since the last report. That entire band sits beneath the prior quarter's range of $6.28 to $20.27, a sign that the stock's center of gravity has shifted downward. Near-term support near $4 is not far away, and reclaiming the long-term average would require a meaningful change in the narrative rather than a modest beat.

Ultimately, this report hinges on a single issue: whether POET can show that commercial revenue is starting to build in a durable way. The per-share loss is likely to remain in the same neighborhood regardless. What matters is whether sales climb toward the $1.6 million consensus and whether management can credibly connect that figure to a path of continued sequential growth. If it can, the steep selloff may look overdone. If it cannot, the market's skepticism will have been justified.